House Panel Criticizes FDA Role in Drug Cases

WASHINGTON, April 22 (Reuters) - Lax U.S. oversight of drug ingredient makers in China and other countries is putting Americans at risk of exposure to more dangerous medicines like the tainted blood-thinner heparin, lawmakers said on Tuesday.